Delivery Order SPE2DB24D1107-SPE2DB25FZFN9
Award Date
6/5/25
Potential Completion Date
6/6/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $22,462.49, is for the supply of Glimepiride 4 mg tablets in 100-count bottles. The contract has a firm-fixed-price structure and a completion date of September 24, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The order, valued at $2,388.72, is a firm fixed-price contract with an ultimate completion date of August 2, 2024. Amerisourcebergen is providing these prescription medications without any set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999, held...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.72 contract is for the delivery of Glimepiride 4 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a $3,591.30 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 4,564,312,918 Glimepiride 4 mg tablets in 100-count bottles. This order is placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through December 31, 2025. The...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of glimepiride 4 mg tablets in 100-count bottles. The contract has a ceiling value of $2,106.69 and is a firm-fixed-price delivery order contract with a period of performance through May 28, 2025. The contract is not set aside and allows for the provision of both brand-name and generic medications to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,889.98, is for the delivery of 4,566,736,019 units of the medication Glimepiride 4 mg tablet in bottles of 100. The contract is a firm fixed-price delivery order, with an ultimate completion date of December 17, 2024. This award is part of AmerisourceBergen's...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $8,550.43 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,455,148 units of the pharmaceutical drug Glimepiride 4 mg tablets in 100-count bottles. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the purchase of GLIMEPIRIDE 2 MG TABLET 100S. The contract has a ceiling value of $1,226.55 and runs through May 6, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides medical products and prescription drugs to federal government agencies, with a significant focus on supporting military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of glimepiride 4 mg tablets. The contract is a delivery order with a firm fixed price of $2,283.44 and a completion date of March 12, 2025. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,326.08, is for the delivery of 4,568,142,317 units of the diabetes medication Glimepiride 2 mg tablets. The contract has a period of performance through May 6, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...